STAAR Surgical FY26 Q2 net income swings to USD 8.1 million; net sales more than doubled to USD 93.5 million year over year

• STAAR Surgical posted Q2 2026 net sales of $93.5 million, more than doubled year over year.
• Net income swung to $8.1 million, or $0.16 per diluted share, from a year-ago net loss.
• Gross margin widened 0.5 percentage points to 74.5%.
• Non-GAAP adjusted EBITDA swung to $20 million, or $0.39 per diluted share, from a year-ago adjusted EBITDA loss.
• China net sales rose to $52.3 million; cash and investments climbed to $181.5 million, with no outstanding debt.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. STAAR Surgical Company published the original content used to generate this news brief via Business Wire (Ref. ID: 20260812574801) on August 12, 2026, and is solely responsible for the information contained therein.